Quantifying cholesterol synthesis in vivo using (2)H(2)O: enabling back-to-back studies in the same subject |
| |
Authors: | Previs Stephen F Mahsut Ablatt Kulick Alison Dunn Keiana Andrews-Kelly Genevieve Johnson Christopher Bhat Gowri Herath Kithsiri Miller Paul L Wang Sheng-Ping Azer Karim Xu Jing Johns Douglas G Hubbard Brian K Roddy Thomas P |
| |
Affiliation: | *Atherosclerosis, Merck Research Laboratories, Rahway, NJ;†Laboratory Animal Resources, Merck Research Laboratories, Rahway, NJ;§Modeling and Simulation, Merck Research Laboratories, Rahway, NJ |
| |
Abstract: | ![]() The advantages of using (2)H(2)O to quantify cholesterol synthesis include i) homogeneous precursor labeling, ii) incorporation of (2)H via multiple pathways, and iii) the ability to perform long-term studies in free-living subjects. However, there are two concerns. First, the t(1/2) of tracer in body water presents a challenge when there is a need to acutely replicate measurements in the same subject. Second, assumptions are made regarding the number of hydrogens (n) that are incorporated during de novo synthesis. Our primary objective was to determine whether a step-based approach could be used to repeatedly study cholesterol synthesis a subject. We observed comparable changes in the (2)H-labeling of plasma water and total plasma cholesterol in African-Green monkeys that received five oral doses of (2)H(2)O, each dose separated by one week. Similar rates of cholesterol synthesis were estimated when comparing data in the group over the different weeks, but better reproducibility was observed when comparing replicate determinations of cholesterol synthesis in the same nonhuman primate during the respective dosing periods. Our secondary objective was to determine whether n depends on nutritional status in vivo; we observed n of ~25 and ~27 in mice fed a high-carbohydrate (HC) versus carbohydrate-free (CF) diet, respectively. We conclude that it is possible to acutely repeat studies of cholesterol synthesis using (2)H(2)O and that n is relatively constant. |
| |
Keywords: | stable isotopes mass spectrometry kinetic biomarker dyslipidemia cardiovascular disease |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|